amycretin vs retatrutide Semaglutide: Next-Gen Dual GLP-1/Amylin vs Proven GLP-1 - Which Is Better? | PPW 9 Obesity Drugs to be

Starting at the lower end (200-250mcg) allows tolerance assessment and side effect minimization before increasing to therapeutic doses, while taking doses higher than prescribed does not necessarily lead to additional benefit and may increase the risk of side effects due to physiologic feedback mechanisms

Rose-John S, Jenkins BJ, Garbers C, Moll JM, Scheller J

156 SuzukiK.HaradaN.YamaneS.NakamuraY.SasakiK.NasteskaD.et al (2013)

In the safety outcomes trial (DEVOTE), a total of 1983 (52%) of the 3818 TRESIBA treated patients with type 2 diabetes were 65 years or older and 381 (10%) were 75 years or older

Abstracts: CLINICAL VIGNETTES/CASE REPORTS - LIVER Drug-induced Liver Injury Associated with the Glucagon-like Peptide 1 (GLP-1) Agonist Liraglutide 1131 Emily Kern Lisa VanWagner Mary Rinella American Journal of Gastroenterology 108:p S335-S336, October 2013

Neuroprotective effects of the novel Glp-1 long acting analogue semaglutide in the Mptp Parkinson's disease mouse model